GENETIC ANALYSIS NK -60 (8V8) — Free Cash Flow Generation Index

Latest as of December 2025: 0.83x

GENETIC ANALYSIS NK -60 (8V8) has a Free Cash Flow Generation Index of 0.83x as of December 2025. Free cash flow of €6.67 Million represents 1% of operating cash flow (€8.04 Million). Read how much debt does GENETIC ANALYSIS NK -60 carry for a breakdown of total debt and financial obligations.

FCF Generation Index

0.83x
Free Cash Flow / Operating CF

Free Cash Flow

€6.67 Million
EUR

Operating Cash Flow

€8.04 Million
EUR

Capital Expenditures

€1.36 Million
EUR

GENETIC ANALYSIS NK -60 Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for GENETIC ANALYSIS NK -60 across 1 annual periods. Explore GENETIC ANALYSIS NK -60 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for GENETIC ANALYSIS NK -60 (2025–2025)

Year-by-year Free Cash Flow Generation Index for GENETIC ANALYSIS NK -60. For the full company profile including market capitalisation, see GENETIC ANALYSIS NK -60 stock valuation.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 -1.31x €-3.13 Million €2.40 Million €5.54 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).